Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD63 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
mRNA | MYLK | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | PPP1CC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | SYNPO | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | NUP54 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | PODN | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | IRF8 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | FNDC10 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | CCAR1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | CNTRL | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |